Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
NCT06399055
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Endocrine, Nutritional and Metabolic Diseases
Interventions
DRUG:
CKD-387
DRUG:
D484
Sponsor
Chong Kun Dang Pharmaceutical